Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Parent Canon (7751.T) group FY2025 revenue ¥4.62tn (+2.5%); operating margin 9.8%; net income ¥332.1bn.
Medical unit: sales ¥580.6bn (+2.1%), operating profit ¥32.8bn (prior-year loss).
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving Canon Medical Systems found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Canon Medical Systems found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Aug 2026: Canon Medical Systems USA began a Class 2 FDA recall of Alphenix interventional X-ray systems (10 US units) because screws in the ceiling-suspended arm's movement gear may loosen; users were told to stop use if warning signs appear.
Contract delivery, go-lives, terminations and disputes.
Feb 2026: Norfolk and Norwich University Hospitals directly awarded Canon a £1.34m (ex VAT) contract to maintain four CT scanners at a new community diagnostic centre to 2033. Nov 2024: Cardiff and Vale UHB renewed its ultrasound managed equipment service with Canon to 2031.